Compare OBIO & KWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBIO | KWY |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.9M | 283.2M |
| IPO Year | 2020 | 2013 |
| Metric | OBIO | KWY |
|---|---|---|
| Price | $6.10 | $9.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.25 | N/A |
| AVG Volume (30 Days) | ★ 303.9K | 30.1K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $33,482,000.00 | ★ $134,996,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.43 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1169.22 | 23.42 |
| 52 Week Low | $2.50 | $8.41 |
| 52 Week High | $6.48 | $11.36 |
| Indicator | OBIO | KWY |
|---|---|---|
| Relative Strength Index (RSI) | 57.56 | 38.58 |
| Support Level | $5.71 | $8.41 |
| Resistance Level | $6.48 | $9.60 |
| Average True Range (ATR) | 0.36 | 0.33 |
| MACD | -0.05 | -0.08 |
| Stochastic Oscillator | 23.12 | 15.40 |
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Kingsway Corp is a U.S.-based company employing the Search Fund model to acquire and build great businesses. The company owns and operates a collection of B2B and B2C services companies that are asset-light, growing, profitable, and that have recurring revenues. It seeks to compound long-term shareholder value on a per share basis via its decentralized management model, its talented team of operators, and its tax-advantaged corporate structure.